Bacopa + lycopene + astaxanthin + vitamin B12

Bacopa + lycopene + astaxanthin + vitamin B12 has been studied in 1 paper since 2020: 1 trial in people. The newest paper, Dec 27, 2020: “Improvement of Executive Function after Short-Term Administration of an Antioxidants Mix Containing Bacopa, Lycopene, Astaxanthin and Vitamin B12: The BLAtwelve Study”.

Intervention

1 paper studies it5 findingsUpdated

See all 1 papers on bacopa + lycopene + astaxanthin + vitamin B12

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“The treatment difference was -21.01 s in favor of the active group (95% C.I. -26.80 to -15.2, p < 0.0001).”
Improvement of Executive Function after Short-Term Administration of an Antioxidants Mix Containing Bacopa, Lycopene, Astaxanthin and Vitamin B12: The BLAtwelve StudyNutrients2020doi:10.3390/nu13010056

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • 5 of 5 findings with company ties
  • Human trial1

Studies in people

1 study gave bacopa + lycopene + astaxanthin + vitamin B12 to people and measured what changed.

What changedDesignPeopleSource

down: Decreases trail Making Test Part B-21.01 s, 95% C.I. -26.80 to -15.2

up: Increases letter fluency+4.33 correct words, 95% C.I. +1.83/+6.82

down: Decreases 8-isoprostane-65.31 pg/mL, 95% C.I. -91.72 to -38.8

Randomized trial8 weeks80 peopleaged 60 years or moreOlder adultsNutrients, Dec 27, 2020

What did studies of bacopa + lycopene + astaxanthin + vitamin B12 find?

5

Studies of bacopa + lycopene + astaxanthin + vitamin B12 measured 5 outcomes, among them 8-isoprostane, letter fluency and trail Making Test Part B.

8-isoprostane

downin humans1

1 study
  1. Bacopa + lycopene + astaxanthin + vitamin B12 decreases 8-isoprostane in humans (-65.31 pg/mL, 95% C.I. -91.72 to -38.8).

    “A stunning and statistically significant difference between treatment groups was observed in the changes of 8-isoprostane levels between baseline and both week 4 and week 8.”

    Human trial8 weeksn = 80

    Improvement of Executive Function after Short-Term Administration of an Antioxidants Mix Containing Bacopa, Lycopene, Astaxanthin and Vitamin B12: The BLAtwelve Study

    Nutrients

More on 8-isoprostane

Letter fluency

upin humans1

1 study
  1. Bacopa + lycopene + astaxanthin + vitamin B12 increases letter fluency in humans (+4.33 correct words, 95% C.I. +1.83/+6.82).

    “The increase in letter fluency of VFT was significantly higher in the active group and statistically significant (+5.28 vs. +1.07 words; p < 0.001).”

    Human trial8 weeksn = 80

    Improvement of Executive Function after Short-Term Administration of an Antioxidants Mix Containing Bacopa, Lycopene, Astaxanthin and Vitamin B12: The BLAtwelve Study

    Nutrients

Trail Making Test Part B

downin humans1

1 study
  1. Bacopa + lycopene + astaxanthin + vitamin B12 decreases trail Making Test Part B in humans (-21.01 s, 95% C.I. -26.80 to -15.2).

    “TMT-B increased in the control group (+3.46 s) and decreased in the active group (−17.63 s).”

    Human trial8 weeksn = 80

    Improvement of Executive Function after Short-Term Administration of an Antioxidants Mix Containing Bacopa, Lycopene, Astaxanthin and Vitamin B12: The BLAtwelve Study

    Nutrients

Letter fluency

upin humans1

1 study
  1. Bacopa + lycopene + astaxanthin + vitamin B12 increases letter fluency in humans (healthy) (+5.28 vs. +1.07 words, p < 0.001).

    “The increase in letter fluency in the verbal fluency test (VFT) was also significantly higher in the active group and statistically significant (+5.28 vs. +1.07 words; p < 0.001).”

    Human trialhealthyoral mix8 weeksn = 80

    Improvement of Executive Function after Short-Term Administration of an Antioxidants Mix Containing Bacopa, Lycopene, Astaxanthin and Vitamin B12: The BLAtwelve Study

    Nutrients

More on Letter fluency

Trail Making Test Part B

downin humans1

1 study
  1. Bacopa + lycopene + astaxanthin + vitamin B12 decreases Trail Making Test Part B in humans (healthy) (-21.01 s).

    “The treatment difference was -21.01 s in favor of the active group (95% C.I. -26.80 to -15.2, p < 0.0001).”

    Human trialhealthyoral mix8 weeksn = 80

    Improvement of Executive Function after Short-Term Administration of an Antioxidants Mix Containing Bacopa, Lycopene, Astaxanthin and Vitamin B12: The BLAtwelve Study

    Nutrients

More on Trail Making Test Part B

Latest